EUVIMEDEUVIMED entdecken
Crossref

Tumor Necrosis Factor-Alpha Gene Polymorphism in diabetic patients with Respiratory Failure Undergoing Intensive Care Treatment

Mahaboob Vali Shaik, Munni Shaik, John Basha Shaik, Jayaram G, S Babulal, Nissi Molli, Swarna Deepak Kuragayala

Archives of Advances in Biosciences · 01.05.2025

DOI: 10.22037/aab.v16i1.47424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Advances in Biosciences, erschienen am 01.05.2025. Verfasst von Mahaboob Vali Shaik und 6 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Reactive oxygen species (ROS) levels increase in diabetes mellitus due to excessive glucose oxidation. The inflammatory response in cells triggers the activation of proinflammatory cytokines, including tumour necrosis factor (TNF)-α, interleukin (IL)-1, interleukin (IL)-6, and interleukin (IL)-18. Variations in the promoter region of the TNF-α gene can influence both the susceptibility to and severity of the disease. This research examines the correlation between TNF-α gene polymorphisms and the development of respiratory distress in patients with diabetes who are undergoing treatment in an intensive care unit. Materials and Methods: A total of 100 participants were involved in the study, comprising 50 individuals diagnosed with diabetes and an additional 50 non-diabetic individuals who served as a control group. The nested T-ARMS PCR assay was employed to determine the genotypes associated with the TNF-α T>C single nucleotide polymorphisms (SNPs). Randomly selected samples underwent sequencing to validate the PCR findings, which revealed distinct genotypes for the TNF-α SNPs. Patient data were collected, and laboratory variables were assessed. The information was subsequently entered into SPSS Version 26.

Results

The presence of the heterozygous C/T genotype emerged as a notable risk factor, exhibiting an odds ratio (OR) of 5.87 (65% CI, 1.12 - 27.8) with a p-value of 0.03. In contrast, the homozygous TT genotype did not demonstrate statistical significance, presenting an OR of 1.87 (95% CI, 0.59 - 7.33) and a p-value of 0.25. These findings are derived from the genotyping of the TNF-α (rs1799964) C/T single nucleotide polymorphism (SNP) in a cohort comprising patients experiencing respiratory distress and a control group.

Conclusion

The association between the emergence of respiratory diseases and the TNF-α (rs1799964) T/C polymorphism has been established. This specific genetic variant may represent a potential risk factor for the development of respiratory distress and could also function as a prognostic indicator for patients with diabetes who are undergoing treatment in intensive care units.

Schlagwörter

TNF-αTNF gene polymorphismrs1799964single nucleotide polymorphismsdiabetes mellitusrespiratory failureintensive caregenetic susceptibilityinflammatory cytokinesreactive oxygen species

Zitieren

APA

Shaik, M. V., Shaik, M., Shaik, J. B., G, J., Babulal, S., Molli, N., & Kuragayala, S. D. (2025). Tumor Necrosis Factor-Alpha Gene Polymorphism in diabetic patients with Respiratory Failure Undergoing Intensive Care Treatment. Archives of Advances in Biosciences. https://doi.org/10.22037/aab.v16i1.47424

Vancouver

Shaik MV, Shaik M, Shaik JB, G J, Babulal S, Molli N, et al. Tumor Necrosis Factor-Alpha Gene Polymorphism in diabetic patients with Respiratory Failure Undergoing Intensive Care Treatment. Archives of Advances in Biosciences. 2025. doi:10.22037/aab.v16i1.47424

BibTeX
@article{Shaik2025,
  author = {Shaik, Mahaboob Vali and Shaik, Munni and Shaik, John Basha and G, Jayaram and Babulal, S and Molli, Nissi and Kuragayala, Swarna Deepak},
  title = {Tumor Necrosis Factor-Alpha Gene Polymorphism in diabetic patients with Respiratory Failure Undergoing Intensive Care Treatment},
  journal = {Archives of Advances in Biosciences},
  year = {2025},
  doi = {10.22037/aab.v16i1.47424}
}
Kostenlos starten →